Cisplatin

An anticancer agent

WARNING: This product can expose you to chemicals including Cisplatin, which is [are] known to the State of California to cause cancer. For more information go to www.P65Warnings.ca.gov.

Cisplatin is available from Abcam as ab141398.
Catalog #: 1550 | abID:

Product Details

Alternate Name cis-Dichlorodiammine platinum(II), cis-Platinum(II) diammine dichloride, Cis-Diamineplatinum (II) dichloride
Appearance Yellow soild
CAS # 15663-27-1
Molecular Formula Pt(NH₃)₂Cl₂
Molecular Weight 300.05
Purity ≥98% by HPLC
Solubility DMSO (10 mg/ml)
SMILES N.N.Cl[Pt+2]Cl
InChi InChI=1S/2ClH.2H3N.Pt/h2*1H;2*1H3;/q;;;;+4/p-2
InChi Key BSJGASKRWFKGMV-UHFFFAOYSA-L
PubChem CID 441203
MDL Number MFCD00011623
Handling Protect from light and moisture
Storage Conditions RT
Shipping Conditions RT
USAGE For Research Use Only! Not For Use in Humans.

Details

A platinum coordination complex with potent anti-neoplastic activity.


Why buy BioVision Products?
Innovation
Affordability
Global Presence
Technical Support
BioVision aims to provide our customers innovative tools for accelerating drug discovery and biological research. BioVision offers >8,000 products including the most comprehensive array of assay kits for key targets in Metabolic pathways.
BioVision is committed to providing the highest quality products at a competitive price.
We have a broad network of global distributors who are ready to address your research needs and ensure fast delivery.
Our highly trained Technical Support team provides comprehensive product support and is dedicated to resolving your issues quickly and efficiently.
Tanay Thakar, Ubiquitinated-PCNA protects replication forks from DNA2-mediated degradation by regulating Okazaki fragment maturation and chromatin assembly. Nat Commun., May 2020;  32358495.
Ramy Gadalla, Validation of CyTOF Against Flow Cytometry for Immunological Studies and Monitoring of Human Cancer Clinical Trials. Front Oncol, May 2019;  31165047.
Jianjun Peng, et al., ( 2018) si-TP73-AS1 suppressed proliferation and increased the chemotherapeutic response of GC cells to cisplatin, Oncology Letters, Sep. 2018, 30127981.
For more citations of this product click here